These results were confirmed in vivo in HCC from a DEN-induced cirrhotic rat model in which GNS561 decreased tumor growth and reduced the frequency of CSCs (CD90+CD45-). The gene discussed is PTPRC; the disease is hepatocellular carcinoma.